UNITY Complete® for Expecting Families

Know More. Know Early.

One blood sample from mom. Direct genetic insights about your baby.

Request a Test Kit
A pregnant mother looking at a sonogram of her baby

Recessive Conditions

UNITY Complete is the only non-invasive blood test that looks at baby’s DNA for recessive conditions. Recessive conditions, such as Cystic Fibrosis, are inherited disorders. This means that both parents can pass the condition to a baby. The condition can be passed down, even if the parents show no signs or symptoms. If both parents are carriers of the same condition, there is a higher possibility that the baby will be born with that condition.
_

UNITY Complete doesn't just determine if the parents are carriers. It can look at baby's genetic information found in mom's blood. This genetic information helps to determine how likely it is that baby will actually be born with this condition.
_

UNITY Complete screens for conditions aligned to medical society recommendations: Cystic Fibrosis (CF), Spinal Muscular Atrophy (SMA), Alpha- Thalassemia, Beta- Thalassemia, and Sickle Cell Disease.

Chromosomal Conditions

UNITY Complete also screens for chromosomal conditions, or aneuploidies, like Down syndrome.

These are typically not inherited but occur due to an extra or missing chromosome in the baby. While every pregnancy carries a small risk of chromosomal conditions, factors like the mother’s age can increase this risk.
_
UNITY Complete screens for chromosomal conditions that are routinely offered by OB providers across the United States: T21, T18, T13, Monosomy X, XXY, XYY and XXX.

Already a UNITY patient?

If you would like to access your results, contact us with questions, or schedule a consult with a genetic counselor, please reach out below.

Access your results

Looking for results? Visit our patient portal to view and download your UNITY test results.

Talk to a Genetic Counselor

Have questions? Speak with a licensed genetic counselor about our tests and your results.

Find more help

Need more information? Contact our dedicated patient support team.

Discover The Difference
With UNITY Complete.

Request a Test Kit
Already a UNITY patient?
Click here for options

Early Intervention Can Make A Difference.

Therapies are most effective when initiated before symptoms begin, making prenatal diagnosis critical.

1 in 40

People are carriers for spinal muscular atrophy1

Children with the most common form of SMA have gene therapy available to increase quality of life and life expectancy.
Treatment can start shortly after birth.

1 in 10

African Americans are carriers for sickle cell disease2

In the general population, sickle cell disease is more common than Down Syndrome. Early diagnosis enables connection to a specialty care clinic.

1 in 20

Carriers for alpha-thalassemia globally3

Alpha-thalassemia major most often results in stillbirth and intervention with gene therapy is available on a research basis.

Know More.Know Early.

One blood draw for multiple insights. No male partner sample required for an accurate fetal risk.

~10 weeks

One maternal  blood draw

~11 weeks

UNITY Aneuploidy
Results (+Add-ons)

~12 weeks

UNITY Fetal Risk 
Screen Results*
* Carrier and cell-free DNA for recessive conditions. Fetal Risk via cell-free DNA only performed if patient is determined to be a carrier

Conditions Screened with UNITY Complete

Sickle Cell Disease

Learn more

Cystic Fibrosis

Learn more

Alpha Thalassemia

Learn more

Spinal Muscular Atrophy

Learn more

Beta Thalassemia

Learn more

Down Syndrome

Learn more

Edwards Syndrome

Learn more

Patau Syndrome

Learn more

Jacobs Syndrome

Learn more

Turner Syndrome

Learn more

Triple X Syndrome

Learn more

Klinefelter Syndrome

Learn more

What To Expect.

See what you can expect with the UNITY Complete prenatal test. Request access below and our highly rated team will reach out to unlock access and answer your questions.

Submit your sample

A single blood draw as early as 9 weeks is all it takes.

After the test

The results for chromosomal conditions (and add-ons, such as gender) are made available in ~1 week, and recessive conditions in ~2 weeks. The patient portal has several resources for you while you wait.

ADD ON

You also have the option to Add-on Babypeek™ once you’ve received your UNITY Complete results.

Understanding your results

Our results are thoughtfully designed. They will provide a summary, detailed results, as well as next steps. Licensed genetic counselors are here to answer your questions usually within 1 business day.

Meet with a Genetic Counselor
A pregnant woman

Frequently Asked Questions

Explore our additional resources and find answers to common questions.

UNITY Complete takes advantage of a pregnancy's DNA (circulating cell-free DNA, ccfDNA) floating in the maternal bloodstream to assess for genetic changes. Some of these genetic changes are extremely small - like changes to single genes that can cause recessive conditions. Some of these genetic changes involve the presence of an entire extra chromosome (aneuploidies).

Our specialized QCT technology enables us to be able to count the genetic information we see from both mom and baby in a blood sample, and determine if there are differences that could indicate a baby has a higher chance of being affected with one of these conditions.

UNITY Complete offers multiple genetic insights from a single maternal blood sample. The results you receive will depend on which tests your healthcare provider orders.

UNITY Aneuploidy NIPT screens pregnancies for chromosome conditions caused by extra or missing chromosomes including trisomy 21, trisomy 18, trisomy 13, monosomy X, XXX, XXY, and XYY. UNITY Aneuploidy NIPT can also tell you the baby's gender. For twin pregnancies, you will also learn if your twins are identical or fraternal.

Depending on your clinical picture, your doctor may also order UNITY Fetal RhD NIPT for moms who have a RhD- blood type, UNITY Fetal Antigen NIPT for moms who are alloimmunized to certain antigens, and 22q11.2 microdeletion analysis.

UNITY Fetal Risk Screen determines if a pregnant person is a carrier for cystic fibrosis, spinal muscular atrophy, sickle cell disease, alpha-thalassemia, or beta-thalassemia. If you're found to be a carrier for one of these conditions, the fetal DNA will be screened to determine if there is a high-chance or a low-chance for a pregnancy to be affected with a condition. In some cases, like twin pregnancies or those achieved with an egg donor, we are not able to perform a fetal risk assessment.

Your provider may also order carrier screening for fragile X syndrome. If the mom is determined to be a carrier for this, our assay can perform cell-free DNA analysis to determine if the fetus is a male- this would put the fetus at higher risk to develop Fragile X Syndrome.

We believe every pregnant patient has the right to choose UNITY Complete.

We accept ALL insurances, including Medicaid, and are in-network with the majority of insurance plans across the United States. We recognize that every patient's insurance and financial situation is unique. We have a dedicated patient services team to support patient needs, including payment plans or financial assistance for those who qualify. If you have any questions or concerns with costs, please email us at support@unityscreen.com or call us at 650-460-2551.

Request access to learn more about how UNITY Complete can support you during this exciting time. Please visit the Patient Portal OR Contact Patient Support


Possible results with UNITY Aneuploidy NIPT typically fall into low-risk fetus or high-risk fetus results.

A Low Risk Fetus result means that the chance your pregnancy is affected with the screened conditions is significantly reduced, but not eliminated.

A High-Risk Fetus result means there is an increased chance for your pregnancy to be affected with a specific condition. Confirmatory testing via chorionic villus sampling,  amniocentesis, or postnatal evaluation is recommended.

Note: this result does not guarantee a healthy child and does not eliminate the possibility of other chromosome abnormalities, birth defects, or other genetic conditions.

UNITY Fetal Risk Screen provides maternal carrier screening results (reported as a positive carrier or negative carrier). If a pregnant person is found to be a carrier, fetal testing will automatically be performed via cell-free DNA analysis. Possible results from the fetal testing can fall into decreased/low-risk categories or increased/high-risk categories.

Take The Next Step.

Request access to learn more about how UNITY Complete can support you during this exciting time.

Request a Test Kit
Already a UNITY patient?
Click here for options

References

  1. 1. Keinath MC, Prior DE, Prior TW. Spinal Muscular Atrophy: Mutations, Testing, and Clinical Relevance. Appl Clin Genet. 2021 Jan 25;14:11-25. doi: 10.2147/TACG.S239603. PMID: 33531827; PMCID: PMC7846873

  2. 2. https://www.hematology.org/education/patients/anemia/sickle-cell-trait#:~:text=Sickle%20cell%20trait%20is%20an,people%20from%20Middle%20Eastern%20countries

  3. 3. https://rarediseases.org/rare-diseases/alpha-thalassemia